Nyrada
Menu
NYR:
Market Cap*:
Price Delay ~20min
Home
About Us
Company Overview
Board of Directors
Senior Management
Scientific Advisory Board
Corporate Governance
Programs
Xolatryp
Myocardial Ischemia and Arrhythmia Control
Stroke
Traumatic Brain Injury
Investors
Investor Welcome
Company Fact Sheet
ASX Announcements
Financial Reports
Corporate Announcements
Investor Presentations
Share Price Information
Investors Glossary
Annual Reports
Analyst Reports
Annual General Meeting
Extraordinary General Meeting
Past General Meetings
News & Insights
Presentations & Interviews
Media
Newsletters
Publications
Contact Us
Contact Us
Working at Nyrada
Email Alerts
News & Insights
Home
>
News & Insights
>
Presentations & Interviews
Presentations & Interviews
Media
Newsletters
Publications
Presentations & Interviews
Filter by Year:
2026
2025
2024
2022
2021
Older
16-Dec-2025
Prof William Chan on Nyrada's Phase IIa clinical trial of Xolatryp
26-Nov-2025
Investor Presentation
12-Nov-2025
AGM Presentation
10-Nov-2025
Investor Presentation and CEO AGM Presentation
2-Oct-2025
ASX Briefs - Inside Nyrada's Bid to Protect the Brain and Heart After Attack
23-Jun-2025
Nyrada Investor Presentation - June 2025
21-May-2025
Nyrada’s drug candidate aims to protect brain and heart cells
1
